跳轉至內容
Merck
  • Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase.

Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase.

Bioorganic & medicinal chemistry letters (2011-07-22)
Richard Ducray, Iain Simpson, Frederic H Jung, J Willem M Nissink, Peter W Kenny, Martina Fitzek, Graeme E Walker, Lara T Ward, Kevin Hudson
摘要

We disclose a novel series of insulin-like growth factor-1 receptor kinase inhibitors based on the 3-(pyrimidin-4-yl)-imidazo[1,2-a]pyridine scaffold. The influence on the inhibitory activity of substitution on the imidazopyridine and at the C5 position of the pyrimidine is discussed. In the course of this optimization, we discovered a potent and selective inhibitor with suitable pharmacokinetics for oral administration.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
咪唑并[1,2-a]吡啶, 99%